Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sanofi India Ltd

SANOFI.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: BUY

Last Close

$33.98

▼ -0.18%

Market Cap $782.54M · Vol 6.33K

Key Metrics

P/E Ratio

23.07

FWD: 18.85

Market Cap

$782.54M

Small Cap

Div Yield

3.79%

Semi-annual dividend

EPS Growth

+25.09%

YoY

RSI (14)

36.02

Momentum

Beta

1.03

vs Market

52W High

$55.44

43.96% below

52W Low

$32.00

5.70% above

Volume

6.33K

Avg 26.00K

P/B

12.56

Price-to-book

ROE

37.20%

Return on equity

Free Float

39.40%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sanofi India Ltd (SANOFI.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SANOFI.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.18%

-3.55%

+0.08%

-19.67%

YTD

-20.66%

-36.11%

-36.43%

-33.26%

Financials & Valuation

TTM · Annual

Total Revenue	$204.49M
Net Income	$36.36M
Revenue Growth (YoY)	+7.73%
Gross Margin	47.86%
Operating Margin	24.71%
Net Profit Margin	17.78%
ROE	37.20%
ROA · ROIC	31.03% · 39.83%

P/E Ratio	23.07
Forward P/E (FY1)	18.85
PEG Ratio	6.95
P/S	5.12
P/B	12.56
P/FCF	22.14
EPS Growth	+25.09%
Outstanding Shares	23.03M

Technical Indicators

50-Day SMA	$35.01
200-Day SMA	$39.38
RSI (14)	36.02
Beta	1.03
52-Week High	$55.44
52-Week Low	$32.00

Volume Today	6.33K
Avg Daily Volume (30D)	26.00K
Relative Volume	0.24x
Volatility (10D)	17.29
Volatility (30D)	16.71
Free Float	39.40%

Analyst Consensus

BUY

Current Price $33.98

Mean Target $47.07

52W Low$32.00 52W High$55.44

Current

Target

$32.00 $55.44

Current Analyst target

+38.52% upside potential · 3 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S83KS1

ISININE058A01010

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.